Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -31.91% is 57% above its 5-year average of -74.90%, near the high end of its 5-year range (-133.13%–-30.23%).
0.42% below its 12-month average of -31.78%.
Reported quarterly operating margin; no daily interpolation. Q3 FY2026 (2026-06-30): -30.65%.
OPERATING MARGIN
-31.91%
OPERATING MARGIN AVG TTM
-31.78%
OPERATING MARGIN AVG 3Y
-53.48%
OPERATING MARGIN AVG 5Y
-74.90%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.42%
CURRENT VS 3Y AVG
+40.34%
CURRENT VS 5Y AVG
+57.40%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Twist Bioscience Corporation
Market Cap
$10.55B
Operating Margin
-31.91%
TTM Avg
-31.78%
3Y Avg
-53.48%
5Y Avg
-74.90%
Market Cap
$10.75B
Operating Margin
11.36%
TTM Avg
11.05%
3Y Avg
9.46%
5Y Avg
10.06%
Market Cap
$10.83B
Operating Margin
16.56%
TTM Avg
16.77%
3Y Avg
12.22%
5Y Avg
7.02%
Market Cap
$10.19B
Operating Margin
-14.33%
TTM Avg
-24.55%
3Y Avg
-31.13%
5Y Avg
-27.31%
Market Cap
$10.33B
Operating Margin
20.75%
TTM Avg
11.46%
3Y Avg
13.43%
5Y Avg
14.29%
Market Cap
$10.30B
Operating Margin
-226.00%
TTM Avg
-1280.12%
3Y Avg
-51793.49%
5Y Avg
-46507.49%
Market Cap
$10.97B
Operating Margin
12.85%
TTM Avg
17.41%
3Y Avg
16.25%
5Y Avg
15.86%
Market Cap
$10.21B
Operating Margin
0.66%
TTM Avg
2.96%
3Y Avg
3.72%
5Y Avg
4.01%
Market Cap
$10.20B
Operating Margin
13.33%
TTM Avg
15.23%
3Y Avg
16.08%
5Y Avg
17.45%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Twist Bioscience Corporation (TWST) | $10.55B | -31.91% | -31.78% | -53.48% | -74.90% |
| Universal Health Services, Inc. (UHS)vs › | $10.75B | 11.36% | 11.05% | 9.46% | 10.06% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.83B | 16.56% | 16.77% | 12.22% | 7.02% |
| 10x Genomics, Inc. (TXG)vs › | $10.19B | -14.33% | -24.55% | -31.13% | -27.31% |
| Globus Medical, Inc. (GMED)vs › | $10.33B | 20.75% | 11.46% | 13.43% | 14.29% |
| ImmunityBio, Inc. (IBRX)vs › | $10.30B | -226.00% | -1280.12% | -51793.49% | -46507.49% |
| The Cooper Companies, Inc. (COO)vs › | $10.97B | 12.85% | 17.41% | 16.25% | 15.86% |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | 0.66% | 2.96% | 3.72% | 4.01% |
| Align Technology, Inc. (ALGN)vs › | $10.20B | 13.33% | 15.23% | 16.08% | 17.45% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 8.52% | 8.41% | 8.37% | 8.78% |
Gross Margin
52.0%
Operating Margin
-31.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -30.65% |
| 2026-03-31 | -34.92% |
| 2025-12-31 | -31.73% |
| 2025-09-30 | -30.23% |
| 2025-06-30 | -31.36% |
| 2025-03-31 | -44.79% |
| 2024-12-31 | -39.05% |
| 2024-09-30 | -42.55% |
| 2024-06-30 | -109.15% |
| 2024-03-31 | -64.92% |
| 2023-12-31 | -65.70% |
| 2023-09-30 | -74.85% |
| 2023-06-30 | -95.36% |
| 2023-03-31 | -102.42% |
| 2022-12-31 | -82.28% |
| 2022-09-30 | -99.24% |
| 2022-06-30 | -109.00% |
| 2022-03-31 | -126.34% |
| 2021-12-31 | -133.13% |
| 2021-09-30 | -104.90% |
| 2021-06-30 | -120.28% |
| 2021-03-31 | -121.79% |
| 2020-12-31 | -116.45% |
| 2020-09-30 | -73.90% |
| 2020-06-30 | -132.96% |
| 2020-03-31 | -166.27% |
| 2019-12-31 | -325.27% |
| 2019-09-30 | -200.62% |
| 2019-06-30 | -206.77% |
| 2019-03-31 | -193.72% |
| 2018-12-31 | -199.24% |
| 2018-09-30 | -234.38% |
| 2018-06-30 | -267.33% |
| 2018-03-31 | -269.51% |
| 2017-12-31 | -388.38% |
| 2017-09-30 | -479.60% |
| 2017-06-30 | -448.36% |
